CDMO INJECTABLE DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

CDMO Injectable Drugs Market, By Product Type (Small Molecule Injectables and Large Molecule Injectables), By Drug Class (Antidiabetics, Cardiovascular Drugs, Anti-infectives, Analgesics and Anesthetics, Oncology Drugs, Vaccines, CNS Drugs, Hormonal Drugs, and Others), By Application (Oncology, Diabetes, Autoimmune Diseases, Hematological Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Pain Management, Rare Diseases, and Others), By Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others), By Scale of Operations (Preclinical Development, Clinical Development (Phases I–III), and Commercial / Large-Scale Manufacturing), By End User (Biopharmaceutical Companies, Generic Drug Manufacturers, Contract Research Organizations (CROs), and Academic and Research Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 16 Apr, 2026
Code: CMI9438
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

The global CDMO injectable drugs market is estimated to be valued at USD 18,650.1 Mn in 2026 and is expected to reach USD 32,819.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033. Global CDMO injectable drugs market represents one of the important segments within the pharmaceutical industry and is formed by organizations that are engaged in contract development and manufacturing activities related to sterile injectables. Such firms have become indispensable suppliers of outsourced services related to the complex process of manufacturing that requires special equipment, knowledge, and high-quality control. Injectable products (IV, IM, and SC injections) require careful treatment, and this makes involvement of CDMOs a necessity for the pharmaceutical industry.

There are several important segments of the analyzed market such as oncology, immunology, cardiovascular diseases, CNS disorders, as well as biologics and biosimilars. Due to specialization in particular areas, CDMOs can become very effective partners in manufacturing of various types of pharmaceutical products. Nowadays, CDMOs are becoming increasingly popular among pharmaceutical companies since their activities allow for concentrating efforts on developing new products rather than manufacturing existing drugs.

Market Dynamics

The global CDMO injectable drugs market is propelled by the increased complexity involved in the development of injectables and especially biosimilars, which have specialized manufacturing processes. Increasing healthcare spending, coupled with the growth in elderly populations and prevalence of various chronic diseases, is increasing the demand for various injectable medicines. The patents of various blockbusters have expired, leading to an increased focus on developing biosimilars, which is fueling the importance of CDMOs in injectable market segments.

However, there are some challenges that should be addressed in the industry, among which include strict compliance with regulations such as GMP (good manufacturing practice). Meeting these regulations requires significant capital investment for the purpose of attaining quality control and upgrading the plant. The capital cost required to establish a sterile production facility is relatively high. Moreover, global production networks have been found vulnerable to supply chain disruptions. Nonetheless, opportunities are arising in developing countries where health care infrastructure is improving. Additionally, specialization in personalized medicines and novel drug delivery systems presents CDMOs with chances to differentiate themselves and secure high-end manufacturing contracts.

Key Features of the Study

This report provides in-depth analysis of the global CDMO injectable drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global CDMO injectable drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent, Inc., Samsung Biologics, WuXi Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Recipharm AB, Siegfried Holding AG, and AGC Biologics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global CDMO injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CDMO injectable drugs market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small Molecule Injectables
- Large Molecule Injectables
Drug Class Insights (Revenue, USD Mn, 2021 - 2033)
- Antidiabetics
- Cardiovascular Drugs
- Anti-infectives
- Analgesics and Anesthetics
- Oncology Drugs
- Vaccines
- CNS Drugs
- Hormonal Drugs
- Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Diabetes
- Autoimmune Diseases
- Hematological Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Disorders
- Pain Management
- Rare Diseases
- Others
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Intramuscular (IM)
- Intravenous (IV)
- Subcutaneous (SC)
- Others
Scale of Operations Insights (Revenue, USD Mn, 2021 - 2033)
- Preclinical Development
- Clinical Development (Phases I–III)
- Commercial / Large-Scale Manufacturing
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Generic Drug Manufacturers
- Contract Research Organizations (CROs)
- Academic and Research Institutes
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Lonza Group
- Thermo Fisher Scientific
- Catalent, Inc.
- Samsung Biologics
- WuXi Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- Recipharm AB
- Siegfried Holding AG
- AGC Biologics

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global CDMO Injectable Drugs Market, By Product Type
  - Global CDMO Injectable Drugs Market, By Drug Class
  - Global CDMO Injectable Drugs Market, By Application
  - Global CDMO Injectable Drugs Market, By Route of Administration
  - Global CDMO Injectable Drugs Market, By Scale of Operations
  - Global CDMO Injectable Drugs Market, By End User
  - Global CDMO Injectable Drugs Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
Global CDMO Injectable Drugs Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Small Molecule Injectables
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large Molecule Injectables
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By Drug Class, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Antidiabetics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anti-infectives
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Analgesics and Anesthetics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oncology Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CNS Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hormonal Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By Application, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oncology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Autoimmune Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hematological Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Infectious Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurological Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pain Management
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rare Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Intramuscular (IM)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intravenous (IV)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Subcutaneous (SC)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By Scale of Operations, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Preclinical Development
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinical Development (Phases I–III)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Commercial / Large-Scale Manufacturing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By End User, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Biopharmaceutical Companies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generic Drug Manufacturers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global CDMO Injectable Drugs Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Samsung Biologics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- WuXi Biologics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- FUJIFILM Diosynth Biotechnologies
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Recipharm AB
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Siegfried Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AGC Biologics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘CDMO Injectable Drugs Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now